Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT01339871
Show Display Options
Download search resultsDownload the search results for:
NCT01339871 (1 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Active, not recruiting Phase I Study of Pazopanib and Vorinostat
Condition: Advanced Cancer
Interventions: Drug: Pazopanib;   Drug: Vorinostat

Indicates status has not been verified in more than two years